Christopher Maxwell Fullerton, Director at Paradigm Biopharmaceuticals Ltd., holds 1.07M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF), holds 254.06K shares in XTEK Limited (Ticker: DE:X9L), holds 0.00 shares in Life (Ticker: CORFF). Most recently, Christopher Maxwell Fullerton Bought ― shares of Paradigm Biopharmaceuticals Ltd. on Nov 19, 2019 for an estimated value of 301.05K.